Genome-Wide Location Analysis Reveals Distinct Transcriptional Circuitry by Paralogous Regulators Foxa1 and Foxa2 by Bochkis, Irina M. et al.
Genome-Wide Location Analysis Reveals Distinct
Transcriptional Circuitry by Paralogous Regulators Foxa1
and Foxa2
Irina M. Bochkis1¤, Jonathan Schug1, Diana Z. Ye1, Svitlana Kurinna2, Sabrina A. Stratton2,
Michelle C. Barton2, Klaus H. Kaestner1*
1Department of Genetics and Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of
America, 2Center for Stem Cell and Developmental Biology, Department of Biochemistry and Molecular Biology, University of Texas M. D. Anderson Cancer Center,
Houston, Texas, United States of America
Abstract
Gene duplication is a powerful driver of evolution. Newly duplicated genes acquire new roles that are relevant to fitness, or
they will be lost over time. A potential path to functional relevance is mutation of the coding sequence leading to the
acquisition of novel biochemical properties, as analyzed here for the highly homologous paralogs Foxa1 and Foxa2
transcriptional regulators. We determine by genome-wide location analysis (ChIP-Seq) that, although Foxa1 and Foxa2 share
a large fraction of binding sites in the liver, each protein also occupies distinct regulatory elements in vivo. Foxa1-only sites
are enriched for p53 binding sites and are frequently found near genes important to cell cycle regulation, while Foxa2-
restricted sites show only a limited match to the forkhead consensus and are found in genes involved in steroid and lipid
metabolism. Thus, Foxa1 and Foxa2, while redundant during development, have evolved divergent roles in the adult liver,
ensuring the maintenance of both genes during evolution.
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Introduction
Expansion of transcription factor gene families has greatly
contributed to the complexity of metazoan genomes [1]. Newly
duplicated genes must acquire new functions in order to remain
relevant, otherwise they are lost via mutation over time.
Transcription factor paralogs diversify either by a mutation
arising in cis-regulatory elements, leading to novel expression
patterns, or by divergence in their coding sequence, acquiring new
functions [2]. A modification of the DNA binding domain can
alter the consensus sequence of a transcription factor, while a
change in the interacting domain allows the protein to interact
with new partners and thereby gain new gene targets.
Functional diversification of DNA-binding proteins is of
particular importance since transcription factors control regula-
tory networks that both direct cell specification and patterning in
development and govern cellular homeostasis in differentiated
tissues. While their main function during development is in
directing correct pattern formation [3], transcription factors in
the adult organisms need to be adaptive to different physiological
conditions and respond to variety of signals in the same cell [4].
Hence embryonic gene regulatory networks are ‘‘overwired’’,
having multiple subnetworks with redundant functions where
transcription factors are used numerous times in different
modules to specify structures in different spatiotemporal context,
while networks in differentiated tissues are designed to be more
flexible.
The developmental regulators Foxa1 and Foxa2, members of
the winged helix transcription factor family, share a highly
conserved 100 amino acid DNA binding domain, and have been
shown to cooperate and direct early liver and pancreas develop-
ment [5]. In addition, Foxa2 plays an important role in bile acid
metabolism in the adult liver [6]. Foxa2 is required to prevent
intrahepatic cholestasis and liver injury in mice fed a cholic acid-
enriched diet. Furthermore, expression of FOXA2 is markedly
decreased in liver samples from individuals with different
cholestatic syndromes. Hence, genetic evidence suggests that
Foxa1, the closest paralog to Foxa2, cannot fully compensate for
the loss of Foxa2 in the liver.
Here we investigated whether alterations in the biochemical
properties of close paralogs, as shown by genome-wide target
preferences in vivo, contribute to their evolutionary diversification.
We find that Foxa1 and Foxa2, while redundant during
development, are functionally diversified in the adult liver through
target occupancy, ensuring their evolutionary fitness as distinct
regulators of transcription.
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Results
Foxa1 and Foxa2 cooperate to regulate gene expression
in the fetal liver, but diverge to direct transcription in the
adult liver
Gene duplication followed by functional diversification of the
duplicates is a primary driver of evolution. The developmental
regulators Foxa1 and Foxa2, the closest paralogs in the Foxa
subfamily of winged-helix transcription factors (Figure 1A), have
been shown to collaborate to initiate liver development [5,7]. The
two proteins share a highly similar 100 amino acid DNA binding
domain [8,9], and strong sequence conservation in their
transactivation domains, located at both N and C termini
[10,11] (Figure 1B). However, structural differences exist as well:
threonine 156 of Foxa2 has been suggested as an Akt phosphor-
ylation site [12], and serine 283 has been proposed as a
phosphoacceptor for DNA-dependent protein kinase [13].
In order to ascertain the relative regulatory contributions of
Foxa1 versus Foxa2 during late fetal hepatic development, we
assembled gene expression profiles of mouse liver tissue of Foxa1
and Foxa2 individual mutants, as well as double mutants
(Foxa12/2;Foxa2loxP/loxP;Alfp.Cre), by analyzing RNA isolated on
embryonic day 18. The number of genes dependent on each single
factor was quite limited, compared to the number of genes that
were differentially expressed in the double mutant (Figure 1C),
suggesting that Foxa1 and Foxa2 remain largely redundant at this
late-fetal stage of liver development. This functional redundancy is
supported by the fact that when both genes are ablated using the
Cre/loxP system during fetal liver development in
Foxa1loxP/loxPFoxa2loxP/loxPAlfpCremice, biliary hyperplasia ensues, which
is not seen when either gene is conditionally ablated by itself [14].
Next, we assessed the involvement of Foxa1 and Foxa2 in the
control of the transcriptional program in the adult liver. One
concern regarding the analysis of Foxa1- or Foxa2-specific binding
and regulation of gene expression is the possibility of mutual
compensation. In other words, if one of the factors is missing, the
other might be increased in expression, occupy the previously
unique binding sites, and affect expression of previously unique
targets. To address this issue, we determined the expression of
Foxa factors in the livers of reciprocally mutated mice. In Foxa1-
deficient livers, expression of Foxa1 is virtually undetectable, while
expression of Foxa2 is not changed as compared to wild-type
littermates at both mRNA and protein levels (Figure 2A, 2B).
Foxa2 expression is lost in Foxa2 mutant mice as expected, while
expression of Foxa1 is comparable to that of control mice. Hence,
for both Foxa1 and Foxa2, when one factor is deleted, the paralog
does not compensate for that factor by a change in expression.
We determined gene expression profiles for adult mouse liver
from Foxa1 and Foxa2 [4] single mutants and observed that
overlap among the differentially-expressed genes between the two
mutants is limited (Figure 2C). We verified mRNA levels of several
microarray targets by quantitative real-time PCR (Q-PCR,
Figure 2D) and determined that when expression of a certain
target is significantly altered in one mutant, mRNA levels of this
target are either not changed or follow the opposite pattern in
livers of reciprocal mutant mice. This observation also holds true
for previously published Foxa2 targets [4], which are regulated
differently by Foxa1 (Figure 2E). Thus, in the adult liver, Foxa1
and Foxa2 do not fully compensate for each other, in contrast to
the situation in the fetal organ.
Identification of genomic targets of Foxa1 and Foxa2 in
adult liver reveals common and factor-specific binding
Next, in order to examine how DNA binding influences
differential gene regulation in the adult liver, we analyzed data
Figure 1. Evolution of Vertebrate Foxa Paralogs and Functional
Redundancy in the Fetal Liver. (A) Phylogenetic tree of the Foxa
subfamily of transcriptional regulators. The putative Foxa4 gene was
lost in vertebrates during evolution. (B) Sequence alignment of mouse
Foxa1 and Foxa2 proteins by ClustalW2 algorithm. The winged-helix
DNA binding domain is highlighted in blue. ‘*’, identical residues in all
sequences, ‘:’ highly conserved amino acids; ‘.’ weakly conserved amino
acids. (C) Venn diagram of the number of genes that are differentially
expressed in fetal livers of Foxa1 and Foxa2 single mutants, as well as
the double mutant (shaded in blue) on embryonic day 18.5. The
number of genes dependent on each single factor is small compared to
the number of genes that are differentially expressed in the double
mutant.
doi:10.1371/journal.pgen.1002770.g001
Author Summary
The duplication of a gene from a common ancestor,
resulting in two copies known as paralogs, plays an
important role in evolution. Newly duplicated genes must
acquire new functions in order to remain relevant,
otherwise they are lost via mutation over time. We have
performed genome-wide location analysis (ChIP–Seq) in
adult liver to examine the differences between two
paralogous DNA binding proteins, Foxa1 and Foxa2. While
Foxa1 and Foxa2 bind a number of common genomic
locations, each protein also localizes to distinct regulatory
regions. Sites specific for Foxa1 also contain a DNA motif
bound by tumor suppressor p53 and are found near genes
important to cell cycle regulation, while Foxa2-only sites
are found near genes essential to steroid and lipid
metabolism. Hence, Foxa1 and Foxa2 have developed
unique functions in adult liver, contributing to the
maintenance of both genes during evolution.
Divergent Targets for Foxa Transcription Factors
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from genome-wide location analysis (ChIP-Seq) for Foxa1 and
Foxa2. We identified 5,682 binding sites for Foxa1 and 11,097 for
Foxa2 using the GLITR algorithm [15], of which only 3,120 sites
were bound by both factors (FDR 5%, Figure 3A). However, in
many of the apparently Foxa1- or Foxa2-specific regions there
were overlapping sequence reads from the opposite factor,
indicating that the sites may potentially be common to both
proteins but that the sequence reads did not reach sufficient depth.
To identify truly unique binding sites for each factor for
subsequent analyses, we defined stringent criteria for Foxa1-only
and Foxa2-only binding sites. The set of unique targets (Figure 3A,
yellow circles) contains peaks for the first factor that include at
most one tag per million per kilobase (Kb) for the other (1,816
Foxa1 sites with one or no Foxa2 tag and 5,682 Foxa2 sites with
one or no Foxa1 tag). Specific examples of both common and
unique Foxa1/Foxa2 targets are shown in Figure 3. Foxa1 and
Foxa2 can occupy common binding sites (Figure 3B, top panel) in
the adult liver, or sites specific to either factor (Foxa1 binding site,
Figure 3B, middle panel vs. Foxa2 binding site, Figure 3B, bottom
panel). An intriguing case is shown in Figure 3C, where both
common and unique binding events co-occur at a single locus.
Chromatin-association of both Foxa1 and Foxa2 was previously
correlated with the methylation status of histone H3 lysine 4
[16,17]. Mono-methylated H3K4 (H3K4me1) is enriched at distal
enhancers; therefore, we compared Foxa1 and Foxa2 binding sites
to a profile of H3K3me1 regions in the adult murine liver [17].
While 92 percent of common Foxa1/Foxa2 targets and a majority
of Foxa2-unique sites (68%) were found in H3K4me1 domains,
surprisingly, only twenty-nine percent of Foxa1-specific regions co-
localized with H3K4me1 blocks (Figure 3D), indicating another
functional difference between Foxa1 and Foxa2 in the adult liver.
An example is shown in Figure 3C, where both common and
Foxa2-specific binding events are located in H3K4me1 domains,
while a Foxa1-unique site occurs in the H3K4me1-free region.
Next, we analyzed DNA sequences present in common and
unique binding sites in detail using a variety of computational
tools. Sites that are bound by both Foxa1 and Foxa2 possess
unique properties. Performing de novo motif analysis of these
sequences, we found that all target sequences contain at least one
perfect match to the previously known Foxa consensus binding site
(a 7-mer of 4 possible sequences, with variation in the second and
fifth nucleotide, (T[A/G]TT[G/T]AC), and frequently also a
second Foxa-like motif, containing one or two degenerate
nucleotides (Figure 4A). In addition, we scanned the sequences
with established positional weight matrices (PWMs) from the
Jaspar [18] and Transfac databases [19]. The top motifs enriched
and identified as statistically significant among the common targets
were numerous forkhead motifs, with the lowest p-value corre-
sponding to the matrix for FOXD1 (FOXD1/Jaspar, FREAC4/
Transfac, Table S1). Thus, both de novo motif finding and PWM
scan analysis demonstrated that all sites bound by both Foxa
paralogs contain a strong forkhead consensus sequence. Strikingly,
we observed that sites common to Foxa1 and Foxa2 also have
preferences for sequences flanking the forkhead motif, a ‘‘C’’ one
Figure 2. Foxa1 and Foxa2 Regulate Different Sets of Target Genes in the Adult Liver. (A,B) Expression of Foxa factors in reciprocal mutant
mice. Black bar, wild-type liver, white bar, Foxa1-deficient liver, and grey bar, Foxa2-deficient liver. As expected, Foxa1 mRNA is undetectable in the
Foxa1 Foxa1-deficient liver, while expression of Foxa2 is not changed in absence of Foxa1 compared to control mice on both the mRNA and protein
level. Similarly, expression of Foxa2 is near background levels in Foxa2-deficient livers, while expression of Foxa1 is comparable to that in wild-type
littermates. (C) Venn diagrams of the number of genes that are differentially expressed (|FC|.= 1.5 and FDR= 15%) in adult livers (total,
downregulated, and upregulated) of Foxa1 (pink circles) and Foxa2 mutant (yellow circles) mice. (D) Confirmation of seven microarray targets
changed in expression in the Foxa1-deficient liver by quantitative real-time PCR (qRT-PCR) (top panel). When the mRNA levels of the same genes were
determined in the Foxa2-deficient liver (bottom panel), these targets were either not Foxa2-dependent at all or regulated in the opposite direction.
Values are represented as means plus standard error. P values were determined by Student’s t test. * p-value,0.05. (E) mRNA levels of previously
identified Foxa2 targets in Foxa1 mutant mice. Values are represented as means plus standard error.
doi:10.1371/journal.pgen.1002770.g002
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nucleotide upstream and a ‘‘T’’ immediately downstream of the
core consensus (Figure 4A). Hence, in addition to the well-known
consensus, other nucleotides are likely important for binding by
Foxa factors.
We validated several dual Foxa1 and Foxa2 targets by
quantitative real-time PCR analysis of ChIP-enriched DNA
(Figure 4B). Functional categories over-represented among the
genes bound by both Foxa1 and Foxa2 included ‘embryonic
development’, ‘regulation of transcription’, and ‘lipid metabolism’
(Figure 4C). These results are consistent with previous reports
showing these factors are necessary for initiation of liver
development [5] and that Foxa2 is required for normal bile acid
homeostasis in the adult liver [6]. ‘Metabolism of xenobiotics by
cytochrome p450’, important for hepatocyte function, and
‘vesicular transport and secretion’, previously associated with
Foxa proteins in the endocrine pancreas [20], are among
biological pathways enriched as well. Interestingly, Foxa1 and
Foxa2 also occupy cis-regulatory elements of many diabetes
susceptibility genes, both those mutated in MODY (mature onset
diabetes of the young) and those with alleles associated with
diabetes risk identified by genome-wide association studies
(GWAS) (Table S2). An example is the genomic locus of Fto (fat
mass and obesity associated gene), where Foxa1 and Foxa2 bind
four distinct intronic regions (Figure 4D). These findings suggest
that variant alleles of FOXA1 and FOXA2 might also contribute to
the diabetes risk in human populations.
Among the Foxa1/Foxa2 targets are twelve nuclear hormone
receptors and multiple liver-enriched DNA binding proteins
(Hnf1a, Hnf1b, Hnf4a, Hnf6, Onecut2, Cebpa, Gata6, Hes1,
Hhex, Prox1). In addition, Foxa1 and Foxa2 bind regulatory
regions of three members of the CTF/nuclear factor I family (Nfia,
Nfib, and Nfix) and the transcriptional repressor CTCF.
Interestingly, the recognition motifs for Hnf1a, Hnf4a, Hnf6,
and the nuclear factor I family members are also enriched in the
target sequences bound by both Foxa paralogs (Table S3), thus
suggesting distinct feed-forward regulatory loops in the network of
genes bound by Foxa1 and Foxa2. Dual Foxa1/Foxa2 sites are
distributed near transcription start sites (TSS), with most sites
within ten kilobases (Kb) from TSS (Figure 4E).
Foxa1-only sites have a weak forkhead consensus, are
bound by p53, and are associated with cell cycle genes
Next, we performed de novo motif analysis using the sequences
bound by Foxa1 only, as defined above. The top motif in the
Foxa1-only set (yellow circle) was a weak forkhead motif, with three-
hundred ninety-eight (or twenty-two percent) sequences containing
a perfect Foxa consensus (T[A/G]TT[G/T]AC) (Figure 5A).
Results of scanning the sequences with positional weight matrices
(PWMs) resulted in enrichment of 14 forkhead PWMs (Table S1).
In addition to the forkhead consenus, several other motifs
appeared in the Foxa1-only set. The first (ACATG and ATG
repeats with a spacer in the middle, Figure 5A) comprise portions
of the positional matrix for p53, which is also enriched in both
conservative and semi-conservative sets by scanning analysis. The
second motif closely resembles the PWM of Klf12, also known as
repressor of AP-2alpha (Tfap2a), a transcription factor that
interacts with p53 [21].
Orthogonal analysis of sites bound only bound by Foxa1
(Figure 5A, yellow circle) and gene expression changes in livers of
Foxa1-deficient mice (Figure 5A, light purple circle) shows that
thirty-seven are direct targets of Foxa1. We have shown that
changes in gene expression in Foxa2 mutants is dependent on
physiological state examined [4]. For instance, the number of
Foxa2 direct targets increases significantly on a cholic-acid
Figure 3. Identification of Genomic Targets of Foxa1 and Foxa2 in Adult Liver. (A) Venn diagram showing the results of genome-wide
location analysis for Foxa1 and Foxa2 in the adult liver, identifying 5,562 binding sites for Foxa1 and 11,097 for Foxa2, of which 3,120 were called
bound by both factors by the GLITR algorithm (certain common targets). Many of the apparently Foxa1- or Foxa2-specific regions contained
overlapping reads from the opposite factor, indicating that the sites may be common, but the reads did not reach significant depth to be called by
GLITR. We defined more stringent criteria for Foxa1-only and Foxa2-only binding sites. The sets of unique targets (yellow circles) contain peaks for the
first factor that include at most one tag per million per KB for the other factor (1,816 Foxa1 sites with one or no Foxa2 tag and 5,682 Foxa2 sites with
one or no Foxa1 tag). (B) Foxa1 and Foxa2 can occupy common binding sites (top panel) in the adult liver, or sites specific to either factor (Foxa1-only
binding site, middle panel; Foxa2-only binding site, bottom panel). (C) Both common and unique binding sites for Foxa1 and Foxa2 can co-occur at a
single genomic locus. (D) Comparison of Foxa1 and Foxa2 binding sites to a profile of H3K3me1 regions (purple circle) in the adult mouse liver.
doi:10.1371/journal.pgen.1002770.g003
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enriched diet as compared to standard chow. Hurtado and
colleagues have reported that FOXA1 is necessary for estrogen to
regulate expression of numerous genes in breast cancer cells [22],
and we have just shown that Foxa1 and Foxa2 cooperate in
mediating the effects of estrogens and androgens on liver cancer
risk in response to carcinogens [23]. While deletion of Foxa1 does
not change expression of many genes in the basal state in quiescent
liver, it is thus likely that Foxa1 regulates mRNA levels of
numerous targets in other physiological conditions, such as
proliferation, estrogen response, or androgen response. We also
verified that several ChIP targets in this group were indeed bound
only by Foxa1 by Q-PCR (Figure 5B).
To investigate whether the presence of the motif resembling the
p53 PWM among Foxa1-only targets truly indicated binding by
p53, we performed chromatin immunoprecipitation analysis in
livers of adult wild type mice. p53 occupied the regulatory regions
of previously identified targets, including the alpha-fetoprotein
(AFP) and TNF receptor superfamily Fas genes (Figure 5C, left
panel). To confirm our predictions from the genome-wide location
analysis for Foxa1, we examined p53 binding in twelve additional
cis-regulatory elements of Foxa1-only targets in both wild type and
Foxa1 mutant livers (Figure 5C, left panel). While none of Foxa2-
only sites tested were bound by p53 in wild type livers, p53 was
enriched at nine Foxa1-only sites, including the cell-cycle
associated genes Aatf and Zwint, in wild type livers, and at two
additional sites in Foxa1-deficient livers. In addition, expression of
Zwint is significantly downregulated in livers of Foxa1 mutant
mice, indicating that Foxa1 is essential for full activation of this
gene and potentially regulates mRNA levels of Zwint in concert
with p53 (Figure 5D).
For most sites examined, there was a trend toward increased
enrichment of p53 binding in Foxa1-deficient livers. Foxa1 and
p53 have been shown to have an antagonistic relationship at the
distal promoter element of Afp gene, where the two transcription
factors regulate expression of Afp in opposite directions, and Foxa1
binding is enhanced in p53-null livers [24]. Our data suggest that
the inverse regulatory relationship between Foxa1 and p53 is a
more general phenomenon.
Functional categories over-represented in the genes bound by
only Foxa1 are associated with cell cycle regulation, which is not
surprising as many of them are p53 targets (Figure 5E). ‘Cyclin-
dependent kinase activity’ and ‘cancer’ are among the top
biological pathway enriched among the Foxa1-only gene targets.
Furthermore, numerous motifs that are over-represented in
Foxa1-bound regions are associated with transcription factors that
play an important role in cell cycle regulation, such as Hic1, Klf12
(repressor of Tfap2a), Tfap2a, and Smads (Table S3). Foxa1 has
been shown to facilitate chromatin access to Smad transcription
factors [25], mediators of Tgf-b signaling, a pathway implicated in
cancer [26] and also enriched in Foxa1-only elements.
Our analysis also confirms a number of motifs found previously
in regions bound by Foxa1, such as those of the androgen receptor
(AR) and the upstream stimulatory factor (Usf) [27,28]. Usf has
been shown to interact with Srebp1 [29], and we also find that the
Srebp1 motif is enriched in Foxa1-bound regions. In addition,
consensus sequences for several transcription factors expressed in
Figure 4. Dual Foxa1/Foxa2 Sites Contain a Perfect ForkheadMotif. (A) All sequences bound by both Foxa1 and Foxa2 in the liver contain at
least one perfect match to the Foxa consensus (a 7-mer of 4 possible sequences, with variation in the second and fifth nucleotide, (T[A/G]TT[G/T]AC)),
and often an additional Foxa-like motif, containing one or two degenerate nucleotides. Surprisingly, these sites show additional preferences for
specific bases at positions flanking the forkhead motif, with a ‘‘C’’ occurring frequently one nucleotide upstream, and a ‘‘T’’ enriched immediately
downstream of the core consensus sequence. (B) Confirmation of several common Foxa1/Foxa2 targets by quantitative RT-PCR and three negative
control regions (with low amount of reads, Nc1, Nc2, and Nc3). Binding is expressed as enrichment of immunoprecipitated DNA relative to input DNA
in liver chromatin. (C) Functional categories over-represented in the genes bound by both Foxa1 and Foxa2 include ‘embryonic development’,
‘regulation of transcription’, and ‘lipid metabolism’. Biological pathways enriched for Foxa1/Foxa2 targets are ‘metabolism of xenobiotics’, ‘vesicular
transport’ and ‘receptor tyrosine kinase signaling’. (D) Foxa1 and Foxa2 bind to four distinct intronic regions of Fto (fat mass and obesity associated)
gene, which is associated with the risk of diabetes. (E) Histogram of cis-regulatory elements bound by both Foxa paralogs shows a normal distribution
near transcription start sites (TSS), with most sites within ten kilobases (Kb) from TSS.
doi:10.1371/journal.pgen.1002770.g004
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the kidney as well as the liver, are enriched in regulatory elements
bound only by Foxa1. It is interesting to note that the proximal
promoter of Foxa1 contains a motif for a kidney-enriched nuclear
factor [30]. Hence, Foxa1, but not Foxa2, is expressed in the
kidney [31] and, when deleted, causes nephrogenic diabetes
insipidus [32]. Our analysis suggests that combination of
regulatory motifs present in one tissue can also occur in a different
tissue, preserving the relationship between the transcription factors
that occupy these elements.
Foxa1 also binds to the cis-regulatory elements of additional
transcription factors, their co-activators and targets genes, in
regulatory feed-forward loops. Foxa1 has been shown to cooperate
with the estrogen receptor (ER) in gene activation in breast cancer
cell lines [33,34]. Here we demonstrate that Foxa1 also binds to
the regulatory regions of the gene encoding histone methyltrans-
ferase Smyd3, a coactivator for ER-mediated transcription. Thus,
Foxa1 and its targets constitute a regulatory feed-forward loop,
which likely contributes to Foxa1 function in ER-dependent
cancers (Figure 5F). Foxa1_only sites are more evenly distributed
near TSS (+/2100 Kb) than dual targets with a large proportion
of sites within 10 Kb (Figure 5G).
Foxa2-only sites have a moderately strong forkhead
consensus and are associated with lipid metabolism
genes
Motifs found by de novo analysis for both Foxa2-only set
resemble a stronger forkhead binding site (Figure 6A) than for
Foxa1-only regions. In fact, more than half of these sequences
contain a perfect Foxa consensus (T[A/G]TT[G/T]AC). The top
motifs from scanning analysis of the sequences with Transfac
PWMs include numerous forkhead motifs (Table S1). In summary,
both de novo and PWM scan analysis indicate that the sites bound
by both Foxa factors contain the strongest match to the Foxa
consensus, Foxa2-only regions the next strongest, and Foxa1-only
sites have the weakest forkhead motif.
Surprisingly, in addition to the forkhead consensus, we found that
sequences bound only by Foxa2 have a preference for the
sequence ‘‘TGTT’’ immediately preceding the forkhead motif.
Since the dual-bound regions demonstrate a preference for
different flanking sequences, these data suggest that in addition
to the strength of the forkhead motif, sequences surrounding the
consensus also play a role in differential recruitment of Foxa
factors to DNA.
Figure 5. Foxa1-Specific Targets Are Enriched for p53 Binding Sites. (A) A set of Foxa1-only targets was defined as those sequences that had
one or fewer sequence tags Foxa2 ChIP-Seq data set (yellow circle). Motif analysis of these sequences found in a weaker forkhead consensus. In
addition to the forkhead consensus, several other motifs appeared in this set of sequences. The first (ACATG and ATG repeats with a spacer in the
middle) comprises parts of the positional weight matrix (PWM) for p53. The second closely resembles the PWM of Klf12, also known as repressor of
AP-2alpha (Tfap2a). Orthogonal analysis of sites bound only bound by Foxa1 (yellow circle) and gene expression changes in livers of Foxa1-deficient
mice (light purple circle) shows that thirty-seven are direct targets of Foxa1. (B) Verification of Foxa1-only targets by qPCR. Filled bars, ChIP of liver
chromatin with an anti-Foxa1 antibody, open bars, ChIP with an anti-Foxa2 antibody. Three negative control regions (Nc1, Nc2, and Nc3) with a low
amount of reads are included Binding is expressed as enrichment of the PCR amplicon relative to input DNA in liver chromatin. (C) Binding of p53 to
cis-regulatory elements of its previously identified targets (positive controls), the alpha-fetoprotein (AFP) and TNF receptor superfamily Fas genes and
twelve additional Foxa1-only targets, including cell-cycle associated Aatf and Zwint genes in both wildtype (black bars) and Foxa1 mutant livers
(white bars) (left panel) by ChIP of liver chromatin followed by qPCR. None of Foxa2-only sites tested were bound by p53 in wiltype livers (right panel)
(D) Quantitative RT- PCR analysis for mRNA of Zwint, Zwint mRNA levels are significantly downregulated in livers of Foxa1 mutant mice by 30%,
Values are represented as means plus standard error. P values were determined by Student’s t test. * p-value,0.05 (E) Foxa1 targets are enriched in
genes involved in cell differentiation, morphogenesis, movement, and cellular cycle. (F) A regulatory feed-forward loop involving Foxa1. In the set of
Foxa1-specific targets, Foxa1 binds to regulatory elements of the nuclear receptor Esr2 (estrogen receptor), its co-activator Smyd3, and target gene
Pgr (progesterone receptor). (G) Foxa1 only sites are more distributed more broadly surrounding TSS (+/2100 Kb) than dual Foxa1/Foxa2 targets
(compare to Figure 4E).
doi:10.1371/journal.pgen.1002770.g005
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Integrating the sites bound only bound by Foxa2 (Figure 6A,
yellow circle) and gene expression changes in livers of Foxa2-
deficient mice (Figure 6A, light purple circle) shows that a
substantial fraction of these genes (three-hundred thirty-three or
41 percent) are direct targets of Foxa2. We also verified that
several ChIP targets were indeed bound only by Foxa2 by qPCR
(Figure 6B). Functional analysis of sites bound only by Foxa2
(Figure 6C) is consistent with previous reports that Foxa2 targets
are enriched in genes involved in lipid and steroid metabolism [6]
and carbohydrate metabolism [35]. ‘Abc transporters’, known
targets of Foxa2 [6], and ‘JAK/Stat signaling’, are among the top
biological pathway enriched in these targets. The motifs of other
transcription factors found to be over-represented in the Foxa2-
only bound sequences include liver-enriched Hnf1a and Hnf4a,
also found in dual-bound regions, and homeodomain DNA
binding proteins such as Nfil3, and Hmga1. Nfil3 has been shown
to regulate Cyp7a1, the rate-limiting enzyme in bile acid synthesis
[36] and likely controls expression of other genes crucial to bile
acid homeostasis together with Foxa2. Foxa2-only sites, similar to
dual-bound regions, are distributed near transcription start sites
(TSS), with most sites within ten kilobases (Kb) from TSS
(Figure 6D).
In summary, the closely-related transcriptional regulators Foxa1
and Foxa2 cooperate during development, and but are function-
ally diversified in the adult liver, as indicated by their target
preferences in vivo.
Discussion
Functional diversification of paralogous transcription factors
can arise either by mutation in cis-regulatory elements or changes
in the coding sequence of the proteins [2]. We examined the
acquisition of novel biochemical functions by Foxa1 and Foxa2,
the closest paralogs in the Foxa subfamily of winged-helix
transcription factors, in the adult liver. Genome-wide location
analysis (ChIP-Seq) revealed that Foxa1 and Foxa2 have unique
targets in addition to many common ones, indicative of diverged
function, which is also reflected in the divergent effects on the liver
transcriptome by ablation of either factor. These results are
consistent with an early study by Lai and colleagues who found
that Foxa1 and Foxa2 (Hnf-3a and Hnf-3b) have different
affinities for the two binding sites in the promoter of the TTR
gene in vitro [8]. Differences in DNA binding by the Foxa paralogs
could be the result of a handful of divergent residues in the forkhead
domain itself, and a few amino acid residues located outside the
DNA binding domain that are targeted by post-translational
modifications. Among seven amino acids in the winged-helix DNA
binding domain that differ between Foxa1 and Foxa2, five are
conserved between Foxa1 and the remaining Foxa family member
Foxa3 (Figure S1), indicating that Foxa1 and Foxa3 represent the
ancient precursor gene, while Foxa2 has acquired new mutations
at those positions.
Recently, Kohler and Cirillo have reported that acetylation of
Foxa1 by p300 attenuates binding of Foxa1 to DNA [37]. Multiple
putative acetylation sites, identified by in silico analysis, are
divergent between Foxa1 and Foxa2 and likely contribute to their
specific DNA binding properties. Additionally, a recent study
implicated Foxa2 as a substrate for DNA-dependent protein kinase
(DNA-PK), which targets serine 283 [13]. A mutation of that
residue to alanine resulted in a protein with greater affinity for
sequence-specific DNA-binding. Interestingly, Foxa1 has an
alanine rather than a serine at position 283, evidence for another
functional diversification of the two proteins. Cirillo and colleagues
showed that the C-terminal domain of Foxa1 also enhances DNA-
binding of the protein to the albumin enhancer [38]. While Foxa1
and Foxa2 share strong sequence conservation in their transacti-
vation domains within the C-terminus, the remainder of the C-
terminal domain is quite divergent between the two paralogs.
Binding of Foxa2 to its targets in the adult liver has been studied
previously [15,39,40,41,42]. We reported that Foxa2 is required
for normal bile acid homeostasis and a cluster of categories with
genes involved in lipid and steroid metabolism was identified as
bound by Foxa2 in vivo [6]. The previously reported data sets [4,6]
were comprised of all sites, including those bound by Foxa1 as
well. We also showed that deletion of Foxa2 in hepatocytes affects
expression of hundreds of genes in mice fed a standard diet and
thousands of genes in mice on a cholic acid-enriched diet,
demonstrating that Foxa1 cannot compensate for the loss of its
paralog [4]. Here, we found that Foxa2-only sites are also
associated with genes important to lipid metabolism and contain a
medium-strength forkhead consensus, as well as motifs for liver-
Figure 6. Foxa2-Specific Targets Contain a Medium-Strength
Forkhead Consensus and Control Genes in Steroid and Lipid
Metabolism. (A) The motifs found by de novo analysis for both Foxa2-
only bound set (yellow circle) resemble a forkhead binding site.
Intersection of Foxa2-bound regions and genes differentially expressed
in livers of Foxa2-deficient mice (light purple circle) identified three-
hundred thirty-three direct targets. (B) Validation of Foxa2-only targets
by qPCR. Filled bars, ChIP of liver chromatin with an anti-Foxa1
antibody, open bars, ChIP with an anti-Foxa2 antibody. Binding is
expressed as enrichment of the PCR amplicon relative to input DNA in
liver chromatin. Negative controls (Nc1, Nc2, Nc3) are regions with a low
amount of reads. (C) Foxa2 targets are enriched in genes involved in
lipid and steroid metabolism, protein modification, and carbohydrate
metabolism. (D) Histogram of the distribution of Foxa2-only sites
relative to TSS. Foxa2-only sites, similar to the Foxa1/Foxa2 dual targets
(compare Figure 4E), are distributed normally near transcription start
sites (TSS), with most sites within ten kilobases (Kb) from TSS.
doi:10.1371/journal.pgen.1002770.g006
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enriched transcription factors and nuclear receptors, and AT-rich
motifs, including homeodomain transcription factors, Nfil3, and
Hmga1. Hence, specialization of Foxa paralogs in the adult liver
has resulted in Foxa2 acquiring a specific role in coordinating the
transcriptional regulatory network that controls bile acid and lipid
metabolism.
The function of Foxa1 has been studied primarily in a variety of
cancer cell lines [34,43] and, together with Foxa2, during
embryonic development [14,44,45]. Binding of Foxa1 to its
targets was shown to be required for chromatin-association of
androgen receptor (AR) in prostate cancer cells [27], and the
estrogen receptor (ER) and retinoic acid receptor (RAR), in breast
cancer cell lines [34,46]. Foxa1 was also implicated in cell cycle
regulation in tumor-derived cells [33,47], but a mechanistic model
was not established. We found that Foxa1-only sites are enriched
for binding sites of p53, a tumor suppressor that activates target
genes that induce cell cycle arrest, apoptosis, or senescence. A
single such composite Foxa1/p53 site was previously characterized
in the promoter of the alpha-fetoprotein (Afp) gene [48], which is
expressed during development and repressed in the adult
hepatocyte. We found that a p53 motif is prevalent in numerous
Foxa1-only targets in the adult liver and validated that p53 binds
these sequences. In addition, we detected other motifs corre-
sponding to factors that interact with p53 (Klf12 (repressor of
Tfap2a), Tfap2a, and Smads) or compete with p53 for binding
(Hic1) [49]. This is a novel function of Foxa1, which has
implications for the role of Foxa1 in cell cycle progression and
cancer.
A study by Gao and Matusik (personal communication) to
detect potential DNA binding complexes occupying the TS2
regulatory element of the probasin gene, bound by Foxa1 in the
prostate [27], identified poly (ADP-ribose) polymerase (Parp1) as a
protein also interacting with this region. Parp1, a chromatin-
associated enzyme, is involved in regulation of numerous
processes, including proliferation, recovery from DNA damage,
and tumor transformation. Parp1 modulates stability of p53 in
unstressed cells [50] and interacts with androgen receptor (AR)
[51], retinoic acid receptor (RAR) [52], proteins functionally
linked with Foxa1, and may interact with Foxa1 itself. These data
support a regulatory network unique to the Foxa1 paralog, one
that functions in cellular growth and genome stability.
In summary, the transcriptional regulators Foxa1 and Foxa2
share a significant fraction of cis-regulatory elements that contain a
high-affinity forkhead binding site and regulate genes essential in
development and those implicated in etiology of diabetes. It is
possible that gene regulatory networks of important disease
susceptibility genes have redundant modules and closely related
paralogs that compensate for each other, as occurs in develop-
mental regulation. However, while Foxa1 retains the more ancient
role of regulating proliferation and growth by influencing DNA
binding of p53, Foxa2 has acquired mutations in its DNA binding
domain and a new role in the hepatocyte, regulating genes
involved in lipid metabolism. In this instance, it is more
advantageous for duplicated paralogs to perform different
functions and transduce the many different physiological signals
propagated through differentiated tissues. We propose that this
functional diversification of the Foxa paralogs contributed to the
maintenance of both genes during evolution.
Materials and Methods
Animals
The derivation of Foxa1 null and Foxa1loxP/loxP mice, the Alfp.Cre
transgenic line to achieve hepatocyte-specific deletion of Cre, and
the Foxa2loxP/loxP;Alfp.Cre mouse model has described previously
[35,44,53]. Two- to three-months old male mice were used for all
ChIP-Seq experiments. Embryos at 18.5 days of gestation were
used for gene expression profiling. Mice were genotyped by PCR
of tail DNA as described [35,44,53]. All animal experiments were
conducted with approval of the Institutional Animal Care and Use
Committee of the University of Pennsylvania.
RNA isolation and expression analysis
Liver RNA was isolated from Foxa1 null, Foxa2loxP/loxP;Alfp.Cre,
Foxa12/2;Foxa2loxP/loxP;Alfp.Cre and control embryos (e18.5) and
Foxa1loxP/loxP;Alfp.Cre and control mice (2–3 months), and quanti-
tative reverse transcription-PCR performed as described [35].
Hybridization to Agilent 4644k Whole Mouse Genome Oligo
Microarray and microarray analysis were completed as reported
previously [4]. Five individual samples for each genotype were
analyzed for both embryonic and adult study.
Chromatin immunoprecipitation and ChIP–Seq
ChIP and the following real time PCR reactions were
performed as described [6]. Snap-frozen mouse liver (100 mg)
from wild type mice was used to prepare chromatin. Foxa1–
specific antiserum (a kind gift of G. Schu¨tz, Heidelberg, Germany),
Foxa2-speficic antiserum (a kind gift of J.A. Whitsett), and p53
antibody (Ab1 OP03, Calbiochem) were used for immunoprecip-
itation. ChIP-Seq was performed as reported previously [44].
Western blot analysis
Protein analysis by immunoblot was performed as reported
previously [6]. The primary antibodies used were guinea pig
antibody to Foxa1 (1:1000), rabbit antibody to Foxa2 (1:5000)
(both a kind gift of J.A. Whitsett) and rabbit antibody to TBP
(1:100, Santa Cruz, sc-273).
Sequence analysis
Foxa1 ChIP libraries for five biological replicates and two
input libraries were sequenced in a total of seven lanes to 36
nucleotides. The reads were aligned to the mouse genome (mm8;
NCBI Build 36) using the ELAND aligner (Illumina). Reads with
a unique best alignment were retained for further processing. We
have pooled reads from previously published Foxa2 ChIP-Seq (4
biological replicates, sequenced on GAI) and 2 biological
replicates sequenced on GAII, resulting in 28,625,810 total reads
for Foxa1 ChIP and 32,852,268 total reads for Foxa2 ChIP. The
GLITR algorithm was run 10 times on a random sample of 28
million reads each from Foxa1 or Foxa2 ChIPseq and input
samples which were compared to a large pool of input reads from
multiple mouse tissues. Regions were defined as bound and
subjected to further analysis if identified by GLITR in 3 or more
runs.
The set of all Foxa1 or Foxa2 sites was created by taking the
union of regions from each GLITR analysis and merging regions
that overlapped. The set of common sites was defined as the set of
merged regions. To identify truly unique binding sites for each
factor for subsequent analyses, we defined stringent criteria for
Foxa1-only and Foxa2-only binding sites. The set of unique targets
contains peaks for the first factor that include at most one tag per
million per kilobase (Kb) for the other. All region manipulations
were performed using Perl and R scripts in the TESS Location
Analysis package.
CisFinder [54], RSAT [55], and SCOPE [56] software were
used for de novo motif finding. Sequence alignment of Foxa proteins
was performed by ClustalW2 algorithm [57]. Analysis of
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overrepresented functional categories was carried out as described
previously [4].
The Asap software was used for positional weight matrix
enrichment analysis (parameters: Fisher’s exact test, sequence-
based statistics, PWM Threshold 0.8) [58], scoring the matrices
from Jaspar database and all vertebrate PWMs from TRANSFAC
2009.2 against positive and negative sequence sets. For each
conservative (Foxa1_zero, Foxa2_zero) and semi-conservative set
(Foxa1_one, Foxa2_one) set, analysis was conducted against two
negative data sets: a corresponding set bound by the other factor
(Foxa1_zero as positive, Foxa2_zero as negative) and a set of
background genomic sequences not bound by either Foxa1 or
Foxa2 (Foxa1_zero as positive, background as negative). The set of
sequences bound by both Foxa1 and Foxa2 was scored against one
negative background data set.
The microarray data from this study can be accessed
at ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) under
accession nos. E-MEXP-2106, E-MEXP-3426, and E-MEXP-
3428. The ChIP-seq data from this study can be accessed at GEO
(http://www.ncbi.nlm.nih.gov/geo/) under accession nos.
GSE25836, GSE26729, and GSE33666.
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conserved between Foxa1 and Foxa3 are highlighted in yellow.
‘*’ (identical residues in all sequences), ‘:’ (highly conserved
column), ‘.’ (weakly conserved column).
(PDF)
Table S1 Overrepresented Forkhead Positional Weight Matrices
in Foxa1-specific, Foxa2-specific, and Dual ChIP-Seq Targets.
(XLS)
Table S2 Cis-regulatory Elements of Diabetes Susceptibility
Genes Bound by Both Foxa1 and Foxa2.
(DOC)
Table S3 Overrepresented Other (non-Forkhead) Positional
Weight Matrices in Foxa1-specific, Foxa2-specific, and Dual
ChIP-Seq Targets.
(XLS)
Acknowledgments
We thank Dr. Shridhar Hannenhalli for valuable comments on the
manuscript; Karrie Brondell for taking care of the mouse colony; and Dr.
Nan Gao, Sebastian Rieck, Alan Fox, and Olga Smirnova for technical
assistance.
Author Contributions
Performed and analyzed experiments: IMB JS DZY SK SAS. Wrote and
edited the manuscript: IMB MCB KHK. Obtained funding for the study:
MCB KHK.
References
1. Levine M, Tjian R (2003) Transcription regulation and animal diversity. Nature
424: 147–151.
2. Singh LN, Hannenhalli S (2008) Functional diversification of paralogous
transcription factors via divergence in DNA binding site motif and in expression.
PLoS ONE 3: e2345. doi:10.1371/journal.pone.0002345
3. Davidson EH (2009) Network design principles from the sea urchin embryo.
Curr Opin Genet Dev 19: 535–540.
4. Bochkis IM, Schug J, Rubins NE, Chopra AR, O’Malley BW, et al. (2009)
Foxa2-Dependent Hepatic Gene Regulatory Networks Depend on Physiological
State. Physiol Genomics.
5. Lee CS, Friedman JR, Fulmer JT, Kaestner KH (2005) The initiation of liver
development is dependent on Foxa transcription factors. Nature 435: 944–947.
6. Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, et al. (2008)
Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in
endoplasmic reticulum stress. Nat Med 14: 828–836.
7. Kaestner KH (2005) The making of the liver: developmental competence in
foregut endoderm and induction of the hepatogenic program. Cell Cycle 4:
1146–1148.
8. Lai E, Prezioso VR, Tao WF, Chen WS, Darnell JE, Jr. (1991) Hepatocyte
nuclear factor 3 alpha belongs to a gene family in mammals that is homologous
to the Drosophila homeotic gene fork head. Genes Dev 5: 416–427.
9. Clark KL, Halay ED, Lai E, Burley SK (1993) Co-crystal structure of the HNF-3/
fork head DNA-recognition motif resembles histone H5. Nature 364: 412–420.
10. Qian X, Costa RH (1995) Analysis of hepatocyte nuclear factor-3 beta protein
domains required for transcriptional activation and nuclear targeting. Nucleic
Acids Res 23: 1184–1191.
11. Pani L, Overdier DG, Porcella A, Qian X, Lai E, et al. (1992) Hepatocyte
nuclear factor 3 beta contains two transcriptional activation domains, one of
which is novel and conserved with the Drosophila fork head protein. Mol Cell
Biol 12: 3723–3732.
12. Wolfrum C, Besser D, Luca E, Stoffel M (2003) Insulin regulates the activity of
forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphoryla-
tion and nuclear/cytosolic localization. Proc Natl Acad Sci U S A 100: 11624–
11629.
13. Nock A, Ascano JM, Jones T, Barrero MJ, Sugiyama N, et al. (2009)
Identification of DNA-dependent protein kinase as a cofactor for the forkhead
transcription factor FoxA2. J Biol Chem 284: 19915–19926.
14. Li Z, White P, Tuteja G, Rubins N, Sackett S, et al. (2009) Foxa1 and Foxa2
regulate bile duct development in mice. J Clin Invest 119: 1537–1545.
15. Tuteja G, White P, Schug J, Kaestner KH (2009) Extracting transcription factor
targets from ChIP-Seq data. Nucleic Acids Res 37: e113.
16. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, et al. (2008) FoxA1
translates epigenetic signatures into enhancer-driven lineage-specific transcrip-
tion. Cell 132: 958–970.
17. Robertson AG, Bilenky M, Tam A, Zhao Y, Zeng T, et al. (2008) Genome-wide
relationship between histone H3 lysine 4 mono- and tri-methylation and
transcription factor binding. Genome Res 18: 1906–1917.
18. Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, et al. (2010)
JASPAR 2010: the greatly expanded open-access database of transcription factor
binding profiles. Nucleic Acids Res 38: D105–110.
19. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. (2006)
TRANSFAC and its module TRANSCompel: transcriptional gene regulation in
eukaryotes. Nucleic Acids Res 34: D108–110.
20. Gao N, Le Lay J, Qin W, Doliba N, Schug J, et al. (2010) Foxa1 and Foxa2
maintain the metabolic and secretory features of the mature beta-cell. Mol
Endocrinol 24: 1594–1604.
21. McPherson LA, Loktev AV, Weigel RJ (2002) Tumor suppressor activity of
AP2alpha mediated through a direct interaction with p53. J Biol Chem 277:
45028–45033.
22. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS (2012) FOXA1
is a key determinant of estrogen receptor function and endocrine response. Nat
Genet 43: 27–33.
23. Li Z, Tuteja G, Schug J, Kaestner KH (2012) Foxa1 and Foxa2 are essential for
sexual dimorphism in liver cancer. Cell 148: 72–83.
24. Nguyen TT, Cho K, Stratton SA, Barton MC (2005) Transcription factor
interactions and chromatin modifications associated with p53-mediated,
developmental repression of the alpha-fetoprotein gene. Mol Cell Biol 25:
2147–2157.
25. Taube JH, Allton K, Duncan SA, Shen L, Barton MC (2010) Foxa1 functions as
a pioneer transcription factor at transposable elements to activate Afp during
differentiation of embryonic stem cells. J Biol Chem 285: 16135–16144.
26. Meulmeester E, Ten Dijke P (2011) The dynamic roles of TGF-beta in cancer.
J Pathol 223: 205–218.
27. Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, et al. (2003) The role of
hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in
transcriptional regulation of prostatic genes. Mol Endocrinol 17: 1484–1507.
28. Sun Q, Yu X, Degraff DJ, Matusik RJ (2009) Upstream stimulatory factor 2, a
novel FoxA1-interacting protein, is involved in prostate-specific gene expression.
Mol Endocrinol 23: 2038–2047.
29. Griffin MJ, Wong RH, Pandya N, Sul HS (2007) Direct interaction between
USF and SREBP-1c mediates synergistic activation of the fatty-acid synthase
promoter. J Biol Chem 282: 5453–5467.
30. Peterson RS, Clevidence DE, Ye H, Costa RH (1997) Hepatocyte nuclear
factor-3 alpha promoter regulation involves recognition by cell-specific factors,
thyroid transcription factor-1, and autoactivation. Cell Growth Differ 8: 69–82.
31. Besnard V, Wert SE, Hull WM, Whitsett JA (2004) Immunohistochemical
localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr
Patterns 5: 193–208.
Divergent Targets for Foxa Transcription Factors
PLoS Genetics | www.plosgenetics.org 9 June 2012 | Volume 8 | Issue 6 | e1002770
32. Behr R, Brestelli J, Fulmer JT, Miyawaki N, Kleyman TR, et al. (2004) Mild
nephrogenic diabetes insipidus caused by Foxa1 deficiency. J Biol Chem 279:
41936–41941.
33. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, et al. (2005) From
the Cover: Location analysis of estrogen receptor alpha target promoters reveals
that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A
102: 11651–11656.
34. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, et al. (2005) Chromosome-
wide mapping of estrogen receptor binding reveals long-range regulation
requiring the forkhead protein FoxA1. Cell 122: 33–43.
35. Zhang L, Rubins NE, Ahima RS, Greenbaum LE, Kaestner KH (2005) Foxa2
integrates the transcriptional response of the hepatocyte to fasting. Cell Metab 2:
141–148.
36. Noshiro M, Usui E, Kawamoto T, Kubo H, Fujimoto K, et al. (2007) Multiple
mechanisms regulate circadian expression of the gene for cholesterol 7alpha-
hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis. J Biol
Rhythms 22: 299–311.
37. Kohler S, Cirillo LA Stable chromatin binding prevents FoxA acetylation,
preserving FoxA chromatin remodeling. J Biol Chem 285: 464–472.
38. Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, et al. (2002) Opening of
compacted chromatin by early developmental transcription factors HNF3
(FoxA) and GATA-4. Mol Cell 9: 279–289.
39. Wederell ED, Bilenky M, Cullum R, Thiessen N, Dagpinar M, et al. (2008)
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using
massively parallel sequencing. Nucleic Acids Res 36: 4549–4564.
40. Odom DT, Dowell RD, Jacobsen ES, Nekludova L, Rolfe PA, et al. (2006) Core
transcriptional regulatory circuitry in human hepatocytes. Mol Syst Biol 2: 2006
0017.
41. Rada-Iglesias A, Wallerman O, Koch C, Ameur A, Enroth S, et al. (2005)
Binding sites for metabolic disease related transcription factors inferred at base
pair resolution by chromatin immunoprecipitation and genomic microarrays.
Hum Mol Genet 14: 3435–3447.
42. Odom DT, Dowell RD, Jacobsen ES, Gordon W, Danford TW, et al. (2007)
Tissue-specific transcriptional regulation has diverged significantly between
human and mouse. Nat Genet 39: 730–732.
43. Wang Q, Li W, Zhang Y, Yuan X, Xu K, et al. (2009) Androgen receptor
regulates a distinct transcription program in androgen-independent prostate
cancer. Cell 138: 245–256.
44. Gao N, LeLay J, Vatamaniuk MZ, Rieck S, Friedman JR, et al. (2008) Dynamic
regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas
development. Genes Dev 22: 3435–3448.
45. Ye DZ, Kaestner KH (2009) Foxa1 and Foxa2 control the differentiation of
goblet and enteroendocrine L- and D-cells in mice. Gastroenterology 137: 2052–
2062.
46. Hua S, Kittler R, White KP (2009) Genomic antagonism between retinoic acid
and estrogen signaling in breast cancer. Cell 137: 1259–1271.
47. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M (2006) A
cell-type-specific transcriptional network required for estrogen regulation of
cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20: 2513–2526.
48. Lee KC, Crowe AJ, Barton MC (1999) p53-mediated repression of alpha-
fetoprotein gene expression by specific DNA binding. Mol Cell Biol 19: 1279–
1288.
49. Naqvi A, Hoffman TA, DeRicco J, Kumar A, Kim CS, et al. (2010) A single-
nucleotide variation in a p53-binding site affects nutrient-sensitive human
SIRT1 expression. Hum Mol Genet 19: 4123–4133.
50. Wesierska-Gadek J, Ranftler C, Schmid G (2005) Physiological ageing: role of
p53 and PARP-1 tumor suppressors in the regulation of terminal senescence.
J Physiol Pharmacol 56 Suppl 2: 77–88.
51. Mayeur GL, Kung WJ, Martinez A, Izumiya C, Chen DJ, et al. (2005) Ku is a
novel transcriptional recycling coactivator of the androgen receptor in prostate
cancer cells. J Biol Chem 280: 10827–10833.
52. Pavri R, Lewis B, Kim TK, Dilworth FJ, Erdjument-Bromage H, et al. (2005)
PARP-1 determines specificity in a retinoid signaling pathway via direct
modulation of mediator. Mol Cell 18: 83–96.
53. Kaestner KH, Katz J, Liu Y, Drucker DJ, Schutz G (1999) Inactivation of the
winged helix transcription factor HNF3alpha affects glucose homeostasis and
islet glucagon gene expression in vivo. Genes Dev 13: 495–504.
54. Sharov AA, Ko MS (2009) Exhaustive search for over-represented DNA
sequence motifs with CisFinder. DNA Res 16: 261–273.
55. Thomas-Chollier M, Sand O, Turatsinze JV, Janky R, Defrance M, et al. (2008)
RSAT: regulatory sequence analysis tools. Nucleic Acids Res 36: W119–127.
56. Carlson JM, Chakravarty A, DeZiel CE, Gross RH (2007) SCOPE: a web server
for practical de novo motif discovery. Nucleic Acids Res 35: W259–264.
57. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007)
Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
58. Marstrand TT, Frellsen J, Moltke I, Thiim M, Valen E, et al. (2008) Asap: a
framework for over-representation statistics for transcription factor binding sites.
PLoS ONE 3: e1623. doi:10.1371/journal.pone.0001623
Divergent Targets for Foxa Transcription Factors
PLoS Genetics | www.plosgenetics.org 10 June 2012 | Volume 8 | Issue 6 | e1002770
